The New Investigator Research Grant Program by the Leukemia Research Foundation funds innovative early-career research projects in leukemia and myelodysplastic syndromes.
Funder: Leukemia Research Foundation
Due Dates: February 5, 2027 (Letter of Intent) | April 12, 2027 (Full application, if invited)
Funding Amounts: Up to $150,000 total over two years; no indirect costs allowed.
Summary: Supports creative early-career investigators advancing innovative leukemia or MDS research projects.
Key Information: Two-stage process: LOI required; only invited applicants may submit full proposals.
This program is designed to empower early-career investigators who demonstrate exceptional creativity and propose highly innovative projects in leukemia research. The initiative aims to foster groundbreaking discoveries by supporting diverse researchers and novel approaches that could significantly impact the field of leukemia and myelodysplastic syndromes (MDS). Projects may originate from any country, and the program encourages applications from underrepresented groups in science.